483
Corcept Therapeutics IncorporatedCorcept Therapeutics Incorporated – FDA 483, May 9, 2014
Record Details
Co-Cept Therapeutics Incorporated, a sponsor, was inspected from May 5-9, 2014, revealing significant deficiencies in their postmarketing adverse drug experience reporting system. The firm lacked comprehensive written procedures for the surveillance, receipt, evaluation, and reporting of adverse drug experiences to the FDA. This included inadequate oversight of outsourced pharmacovigilance vendors and a failure to establish procedures for NDA Field Alert Reports.
View Company Profile
ID · e29fa5e1-8f62-47d4-8233-2c983ef5b68f
Other documents for Corcept Therapeutics Incorporated
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.